Assignee profile:

LPATH, INC.

City:

San Diego, California

Country:

United States

Published Applications:

25

Last publication date:

2015-01-29

Patent Grants:

23

Last grant date:

2015-08-11

Top Inventors for applications by LPATH, INC.

These are the the leading inventors for applications assigned to LPATH, INC.:

Recent patent applications by LPATH, INC.

LPATH, INC. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-01-29
US20150031055A1
Chemistry; metallurgy

NOVEL BIOACTIVE LIPID DERIVATIVES, AND METHODS OF MAKING AND USING THE SAME

#2 | 2013-03-07 ✅ Patent 9,102,718 granted on 2015-08-11
US20130058951A1
Chemistry; metallurgy

Anti-S1P antibody treatment of patients with ocular disease

#3 | 2012-05-24
US20120128666A1
Chemistry; metallurgy

METHODS OF INCREASING NEURONAL DIFFERENTIATION USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID

#4 | 2012-04-05 ✅ Patent 8,871,202 granted on 2014-10-28
US20120082665A1
Chemistry; metallurgy

Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

#5 | 2012-01-19 ✅ Patent 9,274,130 granted on 2016-03-01
US20120014944A1
Chemistry; metallurgy

Prevention and treatment of pain using antibodies to lysophosphatidic acid

#6 | 2011-05-19 ✅ Patent 8,401,799 granted on 2013-03-19
US20110118443A1
Chemistry; metallurgy

Antibody design using anti-lipid antibody crystal structures

#7 | 2011-03-31 ✅ Patent 8,604,172 granted on 2013-12-10
US20110076267A1
Chemistry; metallurgy

Humanized antibody compositions and methods for binding lysophosphatidic acid

#8 | 2011-01-27 ✅ Patent 8,361,465 granted on 2013-01-29
US20110020319A1
Chemistry; metallurgy

Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents

#9 | 2010-09-09 ✅ Patent 8,444,970 granted on 2013-05-21
US20100226916A1
Human necessities

Compositions and methods for treating ocular diseases and conditions

#10 | 2010-04-22 ✅ Patent 9,181,331 granted on 2015-11-10
US20100098700A1
Chemistry; metallurgy

Pharmaceutical compositions for binding sphingosine-1-phosphate

#11 | 2010-02-11 ✅ Patent 9,163,091 granted on 2015-10-20
US20100034814A1
Chemistry; metallurgy

Compositions and methods for binding lysophosphatidic acid

#12 | 2010-01-07 ✅ Patent 8,026,342 granted on 2011-09-27
US20100003242A1
Chemistry; metallurgy

Compositions and methods for binding sphingosine-1-phosphate

#13 | 2009-06-11 ✅ Patent 8,067,549 granted on 2011-11-29
US20090148443A1
Chemistry; metallurgy

Humanized antibodies and compositions for binding sphingosine-1-phosphate

#14 | 2009-05-28 ✅ Patent 7,956,173 granted on 2011-06-07
US20090137037A1
Chemistry; metallurgy

Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate

#15 | 2009-05-28 ✅ Patent 8,158,124 granted on 2012-04-17
US20090136483A1
Physics

Compositions and methods for binding lysophosphatidic acid

#16 | 2009-05-21 ✅ Patent 8,025,877 granted on 2011-09-27
US20090130100A1
Chemistry; metallurgy

Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate

#17 | 2009-05-21 ✅ Patent 8,222,373 granted on 2012-07-17
US20090130099A1
Chemistry; metallurgy

Humanized antibodies and compositions for binding sphingosine-1-phosphate

#18 | 2009-03-19 ✅ Patent 8,614,103 granted on 2013-12-24
US20090074789A1
Human necessities

Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions

#19 | 2009-01-08 ✅ Patent 7,829,674 granted on 2010-11-09
US20090010922A1
Chemistry; metallurgy

Compositions and methods for binding sphingosine-1-phosphate

#20 | 2008-06-19 ✅ Patent 9,217,749 granted on 2015-12-22
US20080145360A1
Physics

Immune-derived moieties reactive against lysophosphatidic acid

#21 | 2008-04-17 ✅ Patent 9,274,129 granted on 2016-03-01
US20080090303A1
Physics

Methods and reagents for detecting bioactive lipids

#22 | 2007-12-06 ✅ Patent 8,796,429 granted on 2014-08-05
US20070281320A1
Chemistry; metallurgy

Bioactive lipid derivatives, and methods of making and using same

#23 | 2007-12-06 ✅ Patent 7,862,812 granted on 2011-01-04
US20070280933A1
Chemistry; metallurgy

Methods for decreasing immune response and treating immune conditions

#24 | 2007-09-13 ✅ Patent 7,901,682 granted on 2011-03-08
US20070212348A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation

#25 | 2006-08-03 ✅ Patent 7,794,713 granted on 2010-09-14
US20060171946A1
Chemistry; metallurgy

Compositions and methods for the treatment and prevention of hyperproliferative diseases

AssigneeID:

12694 ⎘